Red cell distribution width (RDW) and outcomes in HFmrEF/HFpEF: Insights from FINEARTS-HF

17 May 2025 (08:55 - 09:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Jawad Haider Butt

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

3 More presentations in this session

Presentation thumbnail

Role of oral semaglutide therapy on incidence of cognitive impairment in a cohort of elderly diabetics with Heart failure with preserved ejection fraction

Professor A. Sciacqua (Catanzaro, IT)

Abstract Slides Video

Presentation thumbnail

Prognostic implications of abnormal right ventricular-pulmonary artery coupling assessed by three-dimensional echocardiography in heart failure with preserved ejection fraction

Professor C. Shim (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Higher prognostic impact of heart failure patients with preserved ejection fraction at younger age: insights from standardized mortality ratios

Doctor C. de Terwangne (Brussels, BE)

Abstract Slides Video

Access the full session

Session thumbnail

Personalised approaches to HFpEF: diagnostic tools, biomarkers, and prognostic insights

The Event

Event poster

Heart Failure 2025

17 May 2025 08:55 CET

You may be interested in

Congress Presentation

Omecamtiv mecarbil and red cell distribution width in patients with heart failure and reduced ejection fraction: results from the GALACTIC-HF trial

Congress Presentation

Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care

Congress Presentation

Finerenone in patients with severe heart failure: the FINEARTS-HF Trial

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources